Insights

Innovative Biocontrol Solutions Biotalys specializes in developing novel protein-based biocontrols that combine high performance with a safe, biological safety profile. This positions them as a promising partner for companies seeking sustainable, effective crop protection products for both pre- and post-harvest applications in organic or integrated farming systems.

Regulatory Approvals and Launch Readiness With their first biofungicide EVOCA nearing approval in the USA and Europe, Biotalys presents an opportunity to target growers and agribusinesses eager to adopt innovative, approved biological solutions, creating a timely sales window for distribution and commercialization efforts.

Partnership and Collaboration Growth Recent collaborations, such as the partnership with AgroFresh on biological fungicides, highlight opportunities to co-develop or distribute cutting-edge sustainable crop protection products, expanding reach into new markets and crop types.

Leadership and Strategic Expansion The appointment of senior executives like a new CFO and a Director of Business Development indicates a focus on scaling operations and forming strategic alliances, which can facilitate entering new markets or enlarging existing customer bases with innovative crop protection solutions.

Funding and Market Potential With a recent funding round of $16 million and revenue in the low millions, Biotalys is positioned for growth, providing opportunities for early adopters and distributors to engage with a company poised to expand its product pipeline and market penetration in sustainable agriculture.

Biotalys Tech Stack

Biotalys uses 8 technology products and services including CVWarehouse, Akamai, Underscore.js, and more. Explore Biotalys's tech stack below.

  • CVWarehouse
    Applicant Tracking Systems
  • Akamai
    Content Delivery Network
  • Underscore.js
    Javascript Libraries
  • DocuSign
    Miscellaneous
  • JavaScript
    Programming Languages
  • PHP
    Programming Languages
  • reCAPTCHA
    Security
  • Vimeo
    Video Players

Media & News

Biotalys's Email Address Formats

Biotalys uses at least 1 format(s):
Biotalys Email FormatsExamplePercentage
First.Last@biotalys.comJohn.Doe@biotalys.com
45%
First.MiddleLast@biotalys.comJohn.MichaelDoe@biotalys.com
5%
First.Last@biotalys.comJohn.Doe@biotalys.com
45%
First.MiddleLast@biotalys.comJohn.MichaelDoe@biotalys.com
5%

Frequently Asked Questions

What is Biotalys's stock symbol?

Minus sign iconPlus sign icon
Biotalys is a publicly traded company; the company's stock symbol is BTLS.BR.

What is Biotalys's official website and social media links?

Minus sign iconPlus sign icon
Biotalys's official website is biotalys.com and has social profiles on LinkedInCrunchbase.

What is Biotalys's SIC code NAICS code?

Minus sign iconPlus sign icon
Biotalys's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Biotalys have currently?

Minus sign iconPlus sign icon
As of December 2025, Biotalys has approximately 70 employees across 2 continents, including EuropeNorth America. Key team members include Chief Executive Officer: K. H.Chief Business Development Officer: K. E. M.Chief Scientific Officer At Biotalys: C. B.. Explore Biotalys's employee directory with LeadIQ.

What industry does Biotalys belong to?

Minus sign iconPlus sign icon
Biotalys operates in the Biotechnology Research industry.

What technology does Biotalys use?

Minus sign iconPlus sign icon
Biotalys's tech stack includes CVWarehouseAkamaiUnderscore.jsDocuSignJavaScriptPHPreCAPTCHAVimeo.

What is Biotalys's email format?

Minus sign iconPlus sign icon
Biotalys's email format typically follows the pattern of First.Last@biotalys.com. Find more Biotalys email formats with LeadIQ.

How much funding has Biotalys raised to date?

Minus sign iconPlus sign icon
As of December 2025, Biotalys has raised $16M in funding. The last funding round occurred on Oct 14, 2024 for $16M.

When was Biotalys founded?

Minus sign iconPlus sign icon
Biotalys was founded in 2013.

Biotalys

Biotechnology ResearchFlanders, Belgium51-200 Employees

We are an agricultural technology (agtech) company developing a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Based on our ground-breaking technology platform, Biotalys is developing a broad pipeline of crop protection products with novel modes of action, addressing key crop pests and diseases across the whole value chain, from soil to plate. Biotalys’ unique protein-based biocontrols aim to combine the high-performance characteristics of chemicals with the clean safety profile of biologicals, making them ideal crop protection agents for both pre- and post-harvest applications. We are on track to have our first biofungicide EVOCA approved in the USA and Europe. Biotalys was founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology) and is listed on Euronext Brussels. The company is based in the biotech cluster in Ghent, Belgium. More information can be found on www.biotalys.com.

Section iconCompany Overview

SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
BTLS.BR
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
51-200

Section iconFunding & Financials

  • $16M

    Biotalys has raised a total of $16M of funding over 9 rounds. Their latest funding round was raised on Oct 14, 2024 in the amount of $16M.

  • $1M$10M

    Biotalys's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $16M

    Biotalys has raised a total of $16M of funding over 9 rounds. Their latest funding round was raised on Oct 14, 2024 in the amount of $16M.

  • $1M$10M

    Biotalys's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.